2.50
-0.01(-0.40%)
Currency In USD
| Previous Close | 2.51 |
| Open | 2.55 |
| Day High | 2.55 |
| Day Low | 2.38 |
| 52-Week High | 4.2 |
| 52-Week Low | 1.87 |
| Volume | 15,241 |
| Average Volume | 33,454 |
| Market Cap | 21.89M |
| PE | -1.12 |
| EPS | -2.23 |
| Moving Average 50 Days | 2.63 |
| Moving Average 200 Days | 2.63 |
| Change | -0.01 |
If you invested $1000 in Lisata Therapeutics, Inc. (LSTA) 10 years ago, it would be worth $12.35 as of August 20, 2025 at a share price of $2.5. Whereas If you bought $1000 worth of Lisata Therapeutics, Inc. (LSTA) shares 5 years ago, it would be worth $75.41 as of August 20, 2025 at a share price of $2.5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025
GlobeNewswire Inc.
Jul 31, 2025 12:00 PM GMT
BASKING RIDGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and othe
Lisata Therapeutics and WARPNINE Announce iLSTA Trial Enrollment Completion and Provide Preliminary Data Update
GlobeNewswire Inc.
Jul 17, 2025 12:00 PM GMT
Compelling new preliminary data consistent with previously reported preclinical findings demonstrating certepetide’s potential ability to enhance the effectiveness of immunotherapyBASKING RIDGE, N.J. and SUBIACO, Australia, July 17, 2025 (GLOBE NEW
Lisata Therapeutics Expands Intellectual Property Portfolio with New Composition of Matter Patent for Certepetide
GlobeNewswire Inc.
Jul 15, 2025 12:00 PM GMT
Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extension This patent covers novel cyclic peptides and their use in treating solid tumors BASKING RIDGE, N.J, July 15, 2025 (GLOBE NEWSW